MGMT and glioblastoma: A recent comprehensive meta-analysis examining studies using different methods for MGMT promotor methylation testing in glioblastoma patients treated with temozolomide showed MSP and pyrosequencing to be superior to immunohistochemistry for MGMT protein but did not provide evidence for best CpG site threshold [25].